The identification of two functionally discrete interferon‐primed macrophages within the same microenvironment, the demonstration of NFKB1 as a pro‐angiogenesis factor and the robustly consistent prognostic significance across all three cancer types offers novel insight into the TME of gynaecologic malignancies. The gene discussed is NFKB1; the disease is cancer.